|
2026-09-11 |
2026-09-09 |
S
Sale
|
Non-Executive Director
|
71,482
-13.8%
175.34
US$433,450
|
71,482
-13.8%
|
175.34
|
US$433,450
|
|
|
2026-09-10 |
2026-09-09 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
86,595
220.00
US$1,077,148
|
86,595
|
220.00
|
US$1,077,148
|
|
|
2026-09-10 |
2026-09-09 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
41,153
258.92
US$627,473
|
41,153
|
258.92
|
US$627,473
|
|
|
2026-08-19 |
2026-08-17 |
S
Sale
|
Non-Executive Director
|
5,000
-100.0%
127.53
US$637,650
|
5,000
-100.0%
|
127.53
|
US$637,650
|
|
|
2026-08-17 |
2026-08-17 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
5,000
127.53
US$637,637
|
5,000
|
127.53
|
US$637,637
|
|
|
2026-08-12 |
2026-08-10 |
S
Sale
|
Chief Operating Officer
Officer
|
239,850
-70.8%
133.27
US$31,964,810
|
239,850
-70.8%
|
133.27
|
US$31,964,810
|
|
|
2026-08-10 |
2026-08-10 |
PrS
Proposed sale
|
Officer
Officer
|
239,850
133.26
US$31,963,198
|
239,850
|
133.26
|
US$31,963,198
|
|
|
2026-08-07 |
2026-08-06 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
18,278
-23.2%
129.40
US$2,365,173
|
18,278
-23.2%
|
129.40
|
US$2,365,173
|
|
|
2026-08-07 |
2026-08-06 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
8,895
-10.1%
127.00
US$1,129,665
|
8,895
-10.1%
|
127.00
|
US$1,129,665
|
|
|
2026-08-06 |
2026-08-06 |
PrS
Proposed sale
|
Officer
Officer
|
27,173
128.61
US$3,494,755
|
27,173
|
128.61
|
US$3,494,755
|
|
|
2026-07-24 |
2026-07-23 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
5,872
-2.2%
106.43
US$624,957
|
5,872
-2.2%
|
106.43
|
US$624,957
|
|
|
2026-07-24 |
2026-07-23 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
4,828
-1.8%
105.62
US$509,933
|
4,828
-1.8%
|
105.62
|
US$509,933
|
|
|
2026-07-23 |
2026-07-23 |
PrS
Proposed sale
|
Officer
Officer
|
10,700
106.06
US$1,134,867
|
10,700
|
106.06
|
US$1,134,867
|
|
|
2026-07-10 |
2026-07-09 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
3,359
-1.3%
118.52
US$398,109
|
3,359
-1.3%
|
118.52
|
US$398,109
|
|
|
2026-07-10 |
2026-07-09 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
2,335
-0.9%
117.62
US$274,643
|
2,335
-0.9%
|
117.62
|
US$274,643
|
|
|
2026-07-10 |
2026-07-09 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
5,005
-1.9%
116.55
US$583,333
|
5,005
-1.9%
|
116.55
|
US$583,333
|
|
|
2026-07-09 |
2026-07-09 |
PrS
Proposed sale
|
Officer
Officer
|
10,699
117.40
US$1,256,029
|
10,699
|
117.40
|
US$1,256,029
|
|
|
2026-07-08 |
2026-07-06 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
7,448
-11.0%
110.60
US$823,749
|
7,448
-11.0%
|
110.60
|
US$823,749
|
|
|
2026-07-08 |
2026-07-06 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
4,854
-6.7%
109.02
US$529,183
|
4,854
-6.7%
|
109.02
|
US$529,183
|
|
|
2026-07-06 |
2026-07-06 |
PrS
Proposed sale
|
Officer
Officer
|
12,302
109.97
US$1,352,864
|
12,302
|
109.97
|
US$1,352,864
|
|
|
2026-06-26 |
2026-06-25 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
1,292
-0.5%
106.27
US$137,301
|
1,292
-0.5%
|
106.27
|
US$137,301
|
|
|
2026-06-26 |
2026-06-25 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
2,456
-0.9%
105.27
US$258,543
|
2,456
-0.9%
|
105.27
|
US$258,543
|
|
|
2026-06-26 |
2026-06-25 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
3,723
-1.4%
104.28
US$388,234
|
3,723
-1.4%
|
104.28
|
US$388,234
|
|
|
2026-06-26 |
2026-06-25 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
1,836
-0.7%
103.10
US$189,292
|
1,836
-0.7%
|
103.10
|
US$189,292
|
|
|
2026-06-26 |
2026-06-25 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
12,091
-4.3%
102.34
US$1,237,393
|
12,091
-4.3%
|
102.34
|
US$1,237,393
|
|
|
2026-06-25 |
2026-06-25 |
PrS
Proposed sale
|
Officer
Officer
|
21,398
103.31
US$2,210,653
|
21,398
|
103.31
|
US$2,210,653
|
|
|
2026-06-24 |
2026-06-22 |
PlS
Planned sale
|
Chief Legal Officer
Officer
|
1,806
-4.6%
95.82
US$173,051
|
1,806
-4.6%
|
95.82
|
US$173,051
|
|
|
2026-06-22 |
2026-06-22 |
PrS
Proposed sale
|
Officer
Officer
|
1,806
95.81
US$173,039
|
1,806
|
95.81
|
US$173,039
|
|
|
2026-06-22 |
2026-06-22 |
PrS
Proposed sale
|
Officer
Officer
|
1,806
95.81
US$173,039
|
1,806
|
95.81
|
US$173,039
|
|
|
2026-06-10 |
2026-06-08 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
6,515
-2.5%
94.03
US$612,605
|
6,515
-2.5%
|
94.03
|
US$612,605
|
|
|
2026-06-08 |
2026-06-08 |
PrS
Proposed sale
|
Officer
Officer
|
6,515
94.03
US$612,576
|
6,515
|
94.03
|
US$612,576
|
|
|
2026-06-05 |
2026-06-05 |
PrS
Proposed sale
|
Officer
Officer
|
1,858
103.77
US$192,811
|
1,858
|
103.77
|
US$192,811
|
|
|
2026-06-05 |
2026-06-05 |
PrS
Proposed sale
|
Officer
Officer
|
1,858
103.77
US$192,811
|
1,858
|
103.77
|
US$192,811
|
|
|
2026-06-05 |
2026-06-05 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
1,858
-3.0%
103.78
US$192,823
|
1,858
-3.0%
|
103.78
|
US$192,823
|
|
|
2026-06-05 |
2026-06-05 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
1,858
-3.0%
103.78
US$192,823
|
1,858
-3.0%
|
103.78
|
US$192,823
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Financial Officer
Officer
|
2,404
-3.4%
102.27
US$245,857
|
2,404
-3.4%
|
102.27
|
US$245,857
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Financial Officer
Officer
|
2,404
-3.4%
102.27
US$245,857
|
2,404
-3.4%
|
102.27
|
US$245,857
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Operating Officer
Officer
|
2,370
-2.3%
102.27
US$242,380
|
2,370
-2.3%
|
102.27
|
US$242,380
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Operating Officer
Officer
|
2,370
-2.3%
102.27
US$242,380
|
2,370
-2.3%
|
102.27
|
US$242,380
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Medical Officer
Officer
|
2,566
-4.0%
102.27
US$262,425
|
2,566
-4.0%
|
102.27
|
US$262,425
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Medical Officer
Officer
|
2,566
-4.0%
102.27
US$262,425
|
2,566
-4.0%
|
102.27
|
US$262,425
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Legal Officer
Officer
|
2,159
-5.2%
102.27
US$220,801
|
2,159
-5.2%
|
102.27
|
US$220,801
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chief Legal Officer
Officer
|
2,159
-5.2%
102.27
US$220,801
|
2,159
-5.2%
|
102.27
|
US$220,801
|
|
|
2026-06-05 |
2026-06-03 |
S
Sale
|
Chair and CEO
Executive Director
|
7,605
-2.8%
102.27
US$777,763
|
7,605
-2.8%
|
102.27
|
US$777,763
|
|
|
2026-06-03 |
2026-06-03 |
PrS
Proposed sale
|
Officer
Officer
|
2,404
102.27
US$245,857
|
2,404
|
102.27
|
US$245,857
|
|
|
2026-06-03 |
2026-06-03 |
PrS
Proposed sale
|
Officer
Officer
|
2,566
102.27
US$262,424
|
2,566
|
102.27
|
US$262,424
|
|
|
2026-06-03 |
2026-06-03 |
PrS
Proposed sale
|
Officer
Officer
|
2,370
102.27
US$242,379
|
2,370
|
102.27
|
US$242,379
|
|
|
2026-06-03 |
2026-06-03 |
PrS
Proposed sale
|
Officer
Officer
|
2,159
102.27
US$220,800
|
2,159
|
102.27
|
US$220,800
|
|
|
2026-06-03 |
2026-06-03 |
PrS
Proposed sale
|
Officer
Officer
|
7,605
102.27
US$777,763
|
7,605
|
102.27
|
US$777,763
|
|
|
2026-05-22 |
2026-05-22 |
PrS
Proposed sale
|
Officer
Officer
|
6,149
108.46
US$666,951
|
6,149
|
108.46
|
US$666,951
|
|
|
2026-05-22 |
2026-05-22 |
PlS
Planned sale
|
Chief Legal Officer
Officer
|
6,149
-12.9%
108.47
US$666,982
|
6,149
-12.9%
|
108.47
|
US$666,982
|
|
|
2026-05-20 |
2026-05-18 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
7,975
-2.8%
106.97
US$853,086
|
7,975
-2.8%
|
106.97
|
US$853,086
|
|
|
2026-05-20 |
2026-05-18 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
11,836
-4.0%
106.39
US$1,259,232
|
11,836
-4.0%
|
106.39
|
US$1,259,232
|
|
|
2026-05-20 |
2026-05-18 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
5,753
-1.9%
105.32
US$605,906
|
5,753
-1.9%
|
105.32
|
US$605,906
|
|
|
2026-05-18 |
2026-05-18 |
PrS
Proposed sale
|
Officer
Officer
|
25,564
106.33
US$2,718,106
|
25,564
|
106.33
|
US$2,718,106
|
|
|
2026-05-15 |
2026-05-14 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
10,479
-13.9%
117.54
US$1,231,702
|
10,479
-13.9%
|
117.54
|
US$1,231,702
|
|
|
2026-05-14 |
2026-05-14 |
PrS
Proposed sale
|
Officer
Officer
|
10,479
117.53
US$1,231,599
|
10,479
|
117.53
|
US$1,231,599
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Chief Legal Officer
Officer
|
4,109
-7.9%
116.18
US$477,384
|
4,109
-7.9%
|
116.18
|
US$477,384
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Chief Financial Officer
Officer
|
8,272
-10.4%
116.18
US$961,041
|
8,272
-10.4%
|
116.18
|
US$961,041
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Chair and CEO
Executive Director
|
13,283
-4.4%
116.18
US$1,543,219
|
13,283
-4.4%
|
116.18
|
US$1,543,219
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Chief Operating Officer
Officer
|
5,837
-5.5%
116.18
US$678,143
|
5,837
-5.5%
|
116.18
|
US$678,143
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Chief Medical Officer
Officer
|
3,384
-4.3%
116.18
US$393,153
|
3,384
-4.3%
|
116.18
|
US$393,153
|
|
|
2026-05-15 |
2026-05-13 |
S
Sale
|
Chief Medical Officer
Officer
|
4,470
-5.4%
112.76
US$504,037
|
4,470
-5.4%
|
112.76
|
US$504,037
|
|
|
2026-05-13 |
2026-05-13 |
PrS
Proposed sale
|
Officer
Officer
|
5,837
116.18
US$678,142
|
5,837
|
116.18
|
US$678,142
|
|
|
2026-05-13 |
2026-05-13 |
PrS
Proposed sale
|
Officer
Officer
|
4,109
116.18
US$477,383
|
4,109
|
116.18
|
US$477,383
|
|
|
2026-05-13 |
2026-05-13 |
PrS
Proposed sale
|
Officer
Officer
|
7,854
114.23
US$897,145
|
7,854
|
114.23
|
US$897,145
|
|
|
2026-05-13 |
2026-05-13 |
PrS
Proposed sale
|
Officer
Officer
|
8,272
116.18
US$961,040
|
8,272
|
116.18
|
US$961,040
|
|
|
2026-05-13 |
2026-05-13 |
PrS
Proposed sale
|
Officer
Officer
|
13,283
116.18
US$1,543,218
|
13,283
|
116.18
|
US$1,543,218
|
|
|
2026-05-13 |
2026-05-11 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
830
-1.0%
101.18
US$83,979
|
830
-1.0%
|
101.18
|
US$83,979
|
|
|
2026-05-13 |
2026-05-11 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
12,119
-12.6%
100.35
US$1,216,142
|
12,119
-12.6%
|
100.35
|
US$1,216,142
|
|
|
2026-05-11 |
2026-05-11 |
PrS
Proposed sale
|
Officer
Officer
|
12,949
100.40
US$1,300,105
|
12,949
|
100.40
|
US$1,300,105
|
|
|
2026-05-06 |
2026-05-04 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
381
-0.1%
139.60
US$53,188
|
381
-0.1%
|
139.60
|
US$53,188
|
|
|
2026-05-06 |
2026-05-04 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
1,247
-0.4%
139.09
US$173,445
|
1,247
-0.4%
|
139.09
|
US$173,445
|
|
|
2026-05-06 |
2026-05-04 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
2,721
-0.9%
137.86
US$375,117
|
2,721
-0.9%
|
137.86
|
US$375,117
|
|
|
2026-05-06 |
2026-05-04 |
PlS
Planned sale
|
Chair and CEO
Executive Director
|
5,318
-1.7%
137.01
US$728,619
|
5,318
-1.7%
|
137.01
|
US$728,619
|
|